GlassScriptPhysician profile
Peter G Weber
NPI 1477533909
$1,517.68
in general payments reported to CMS, 2019-2025
15 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $47.50 · 2021: $165 · 2022: $316 · 2023: $469 · 2024: $227 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $468.80 | 2022-2023 | Lumera 700 |
| Alcon Vision LLC | $240.45 | 2019-2025 | Rocklatan, Clareon |
| Bausch & Lomb Americas INC. | $132.29 | 2023-2025 | Xiidra, Miebo |
| Glaukos Corporation | $127.24 | 2023-2024 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Aerie Pharmaceuticals, INC. | $105.31 | 2020-2021 | |
| Allergan, INC. | $104.93 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $88.39 | 2024-2025 | Xdemvy |
| Abbvie INC. | $61.11 | 2022-2023 | Lumigan |
| Biotissue Holdings INC. | $46.92 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $41.38 | 2023 | Acthar |
| Omeros Corporation | $29.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.26 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $21.34 | 2025 | |
| New World Medical,INC. | $18.27 | 2021 | |
| Lensar, INC. | $3.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.